Fully Human Anti-HCMV Antibody can neutralize free virus in blood and has the capacity for neutralization within cells twice. Currently, there is no HCMV vaccine launched in the world. The product has a precise mechanism of action and excellent safety, and can be produced on a large scale under strict quality control due to its non-blood-derived production process. It is expected to fill the gap of HCMV monoclonal antibodies in the world.
